Elizabeth Lihua BuddeMD, PhD
Dr. Budde's academic and clinical interests include investigating and designing novel means of immunotherapy for patients with lymphoma and leukemia, and she is part of the T Cell Therapeutics Research Laboratory, investigating the use of CAR T cells to treat blood cancers and other diseases.
Board certified in medical oncology and internal medicine, Dr. Budde has received many honors and awards for her work. She was chosen as a Special Fellow in Clinical Research awardee by the Leukemia & Lymphoma Society, a recipient of the Edson Immunotherapy Pilot Award from the J. Orin Edson Foundation and an awardee of the Stop Cancer Foundation seed grant in 2016. She is also a recipient of the prestigious Damon Runyon Cancer Research Foundation Clinical Investigator Award (2014-2017). She has served as the principal investigator on several innovative translational research protocols and has published her work in many peer-reviewed journals, and given presentations at national and international meetings.